Age at assessment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18–40 |
30 |
6 |
16 |
8 |
3 |
5 |
0 |
0 |
1 |
4 |
4 |
13 |
0 |
0 |
1 |
8 |
0 |
0 |
3 |
5 |
0 |
0 |
2 |
17 |
41–65 |
260 |
55 |
115 |
60 |
26 |
43 |
26 |
63 |
14 |
58 |
12 |
39 |
8 |
53 |
7 |
54 |
7 |
39 |
35 |
57 |
3 |
38 |
7 |
58 |
>65 |
184 |
39 |
59 |
31 |
32 |
52 |
15 |
37 |
9 |
38 |
15 |
48 |
7 |
47 |
5 |
38 |
11 |
61 |
23 |
38 |
5 |
63 |
3 |
25 |
Gender |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Female |
309 |
65 |
188 |
98 |
22 |
36 |
22 |
54 |
24 |
100 |
10 |
32 |
6 |
40 |
2 |
15 |
0 |
0 |
27 |
44 |
2 |
25 |
8 |
67 |
Male |
165 |
35 |
2 |
1 |
39 |
64 |
19 |
46 |
0 |
0 |
21 |
68 |
9 |
60 |
11 |
85 |
18 |
100 |
34 |
56 |
6 |
75 |
4 |
33 |
Marital status |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Single |
43 |
9 |
16 |
8 |
3 |
5 |
4 |
10 |
2 |
8 |
3 |
10 |
1 |
7 |
1 |
8 |
2 |
11 |
8 |
13 |
1 |
13 |
2 |
17 |
Married or domestic partnership |
378 |
80 |
153 |
80 |
48 |
79 |
36 |
88 |
17 |
71 |
24 |
77 |
13 |
87 |
12 |
92 |
15 |
83 |
45 |
74 |
7 |
88 |
8 |
67 |
Widowed |
40 |
8 |
17 |
9 |
9 |
15 |
1 |
2 |
2 |
8 |
3 |
10 |
1 |
7 |
0 |
0 |
0 |
0 |
6 |
10 |
0 |
0 |
1 |
8 |
Divorced/Separated |
13 |
3 |
4 |
2 |
1 |
2 |
0 |
0 |
3 |
13 |
1 |
3 |
|
0 |
0 |
0 |
1 |
6 |
2 |
3 |
0 |
0 |
1 |
8 |
Education status |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Elementary school |
57 |
12 |
14 |
7 |
14 |
23 |
5 |
12 |
3 |
13 |
8 |
26 |
0 |
0 |
1 |
8 |
0 |
0 |
9 |
15 |
2 |
25 |
1 |
8 |
Secondary school graduate |
138 |
29 |
56 |
29 |
20 |
33 |
12 |
29 |
9 |
38 |
8 |
26 |
7 |
47 |
7 |
54 |
5 |
28 |
10 |
16 |
2 |
25 |
2 |
17 |
High school graduate |
174 |
37 |
67 |
35 |
16 |
26 |
14 |
34 |
11 |
46 |
12 |
39 |
6 |
40 |
4 |
31 |
9 |
50 |
24 |
39 |
4 |
50 |
7 |
58 |
Graduated |
105 |
22 |
53 |
28 |
11 |
18 |
10 |
24 |
1 |
4 |
3 |
10 |
2 |
13 |
1 |
8 |
4 |
22 |
18 |
30 |
0 |
0 |
2 |
17 |
Employment status |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employed |
159 |
34 |
74 |
39 |
18 |
30 |
15 |
37 |
5 |
21 |
10 |
32 |
2 |
13 |
4 |
31 |
6 |
33 |
16 |
26 |
2 |
25 |
7 |
58 |
Unemployed |
49 |
10 |
21 |
11 |
4 |
7 |
4 |
10 |
8 |
33 |
1 |
3 |
2 |
13 |
1 |
8 |
1 |
6 |
6 |
10 |
1 |
13 |
0 |
0 |
Retired |
230 |
49 |
81 |
42 |
36 |
59 |
19 |
46 |
11 |
46 |
18 |
58 |
5 |
33 |
7 |
54 |
11 |
61 |
29 |
48 |
5 |
63 |
3 |
25 |
Other (student, job-seeker.) |
36 |
8 |
14 |
7 |
3 |
5 |
3 |
7 |
0 |
0 |
2 |
6 |
6 |
40 |
1 |
8 |
0 |
0 |
10 |
16 |
0 |
0 |
2 |
17 |
Diagnosis |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2019–2020 |
296 |
62 |
106 |
55 |
45 |
75 |
29 |
71 |
15 |
62 |
17 |
55 |
12 |
80 |
9 |
69 |
11 |
61 |
47 |
77 |
3 |
38 |
7 |
58 |
2017–2018 |
73 |
15 |
26 |
14 |
9 |
15 |
7 |
17 |
4 |
17 |
6 |
19 |
1 |
7 |
0 |
0 |
4 |
22 |
10 |
16 |
3 |
38 |
0 |
0 |
2016 or before |
105 |
22 |
58 |
30 |
7 |
11 |
5 |
12 |
5 |
21 |
8 |
26 |
2 |
13 |
4 |
31 |
3 |
17 |
4 |
7 |
2 |
25 |
5 |
42 |
ECOG PS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0–1 |
444 |
94 |
184 |
96 |
56 |
92 |
39 |
95 |
22 |
92 |
30 |
97 |
14 |
93 |
11 |
85 |
16 |
89 |
54 |
89 |
8 |
100 |
11 |
92 |
≥2 |
30 |
6 |
6 |
3 |
5 |
8 |
2 |
5 |
2 |
8 |
1 |
3 |
1 |
7 |
2 |
15 |
2 |
11 |
7 |
11 |
0 |
0 |
1 |
8 |
Stage |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
I |
81 |
17 |
43 |
23 |
4 |
7 |
2 |
5 |
2 |
8 |
15 |
48 |
2 |
13 |
2 |
15 |
2 |
11 |
8 |
13 |
0 |
0 |
1 |
8 |
II |
87 |
18 |
37 |
19 |
12 |
20 |
13 |
32 |
3 |
13 |
2 |
6 |
2 |
13 |
2 |
15 |
6 |
33 |
8 |
13 |
0 |
0 |
2 |
17 |
III |
77 |
16 |
27 |
14 |
9 |
15 |
2 |
5 |
10 |
42 |
11 |
35 |
1 |
7 |
4 |
31 |
2 |
11 |
10 |
16 |
0 |
0 |
1 |
8 |
IV |
229 |
48 |
83 |
43 |
36 |
59 |
24 |
59 |
9 |
38 |
3 |
10 |
10 |
67 |
5 |
38 |
8 |
44 |
35 |
57 |
8 |
100 |
8 |
67 |
Anticancer therapy |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chemotherapy |
291 |
61 |
108 |
57 |
38 |
62 |
35 |
85 |
16 |
67 |
15 |
48 |
12 |
80 |
9 |
69 |
8 |
44 |
40 |
66 |
1 |
13 |
9 |
75 |
Target therapy |
109 |
23 |
56 |
29 |
9 |
15 |
4 |
10 |
8 |
33 |
4 |
13 |
2 |
13 |
2 |
15 |
4 |
22 |
14 |
23 |
6 |
75 |
0 |
0 |
Immunotherapy |
47 |
10 |
7 |
4 |
14 |
23 |
2 |
5 |
0 |
0 |
12 |
39 |
1 |
7 |
2 |
15 |
0 |
0 |
7 |
11 |
1 |
13 |
1 |
8 |
Radiotherapy only |
14 |
3 |
11 |
6 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3 |
17 |
0 |
0 |
0 |
0 |
0 |
0 |
Endocrine therapy |
13 |
3 |
8 |
4 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3 |
17 |
0 |
0 |
0 |
0 |
2 |
17 |
Setting of therapy |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Neoadjuvant/Adjuvant/Early or Locally Advanced |
245 |
52 |
109 |
57 |
25 |
41 |
17 |
41 |
15 |
63 |
0 |
0 |
0 |
0 |
8 |
61 |
10 |
56 |
26 |
42 |
0 |
0 |
4 |
33 |
Metastatic 1L |
124 |
26 |
48 |
25 |
19 |
31 |
13 |
32 |
3 |
13 |
23 |
74 |
10 |
67 |
3 |
23 |
3 |
17 |
17 |
28 |
4 |
50 |
5 |
42 |
Metastatic 2L |
60 |
13 |
17 |
9 |
10 |
16 |
7 |
17 |
5 |
21 |
6 |
19 |
4 |
27 |
1 |
8 |
3 |
17 |
9 |
15 |
2 |
25 |
3 |
25 |
Metastatic 3L |
19 |
4 |
6 |
3 |
5 |
8 |
1 |
2 |
1 |
4 |
1 |
3 |
0 |
0 |
0 |
0 |
1 |
6 |
3 |
5 |
1 |
13 |
0 |
0 |
Metastatic subsequent Lines |
26 |
5 |
11 |
6 |
2 |
3 |
3 |
7 |
0 |
0 |
1 |
3 |
1 |
7 |
1 |
8 |
1 |
6 |
6 |
10 |
1 |
13 |
0 |
0 |
Hospital |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AULSS9 Scaligera- Mater Salutis |
177 |
37 |
66 |
35 |
24 |
39 |
11 |
27 |
14 |
58 |
22 |
71 |
6 |
40 |
9 |
69 |
10 |
56 |
1 |
2 |
8 |
100 |
6 |
50 |
AULSS9 Scaligera- Fracastoro |
50 |
11 |
24 |
13 |
1 |
2 |
9 |
22 |
2 |
8 |
9 |
29 |
1 |
7 |
0 |
0 |
1 |
6 |
1 |
2 |
0 |
0 |
2 |
17 |
AULSS9 Scaligera- Magalini |
7 |
1 |
3 |
2 |
1 |
2 |
1 |
2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
6 |
0 |
0 |
0 |
0 |
1 |
8 |
AOUI Ospedale Civile Maggiore |
133 |
28 |
58 |
30 |
22 |
36 |
14 |
34 |
1 |
4 |
0 |
0 |
5 |
33 |
2 |
15 |
2 |
11 |
26 |
43 |
0 |
0 |
3 |
25 |
AOUI Policlinico G.B.Rossi |
107 |
23 |
39 |
20 |
13 |
21 |
6 |
15 |
7 |
29 |
0 |
0 |
3 |
20 |
2 |
15 |
4 |
22 |
33 |
54 |
0 |
0 |
0 |
0 |